The PE Ratio as of November 2024 (TTM) for Brii Biosciences Limited (BRIBF) is -3.66

According to Brii Biosciences Limited’s latest financial reports and current stock price. The company's current PE Ratio is -3.66. This represents a change of -102.43% compared to the average of 150.92 of the last 4 quarters.

Brii Biosciences Limited (BRIBF) Historical PE Ratio (quarterly & annually)

How has BRIBF PE Ratio performed in the past?

The mean historical PE Ratio of Brii Biosciences Limited over the last ten years is -11.01. The current -3.66 PE Ratio has changed 3.23% with respect to the historical average. Over the past ten years (40 quarters), BRIBF's PE Ratio was at its highest in in the September 2023 quarter at 482.04. The PE Ratio was at its lowest in in the December 2022 quarter at -60.66.

Brii Biosciences Limited (BRIBF) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Brii Biosciences Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Brii Biosciences Limited (BRIBF) Average PE Ratio

How has BRIBF PE Ratio performed in the past?

The current PE Ratio of Brii Biosciences Limited (BRIBF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Brii Biosciences Limited (BRIBF) PE Ratio vs. Peers

How is BRIBF’s PE Ratio compared to its peers?

Brii Biosciences Limited’s PE Ratio is less than Avalo Therapeutics, Inc. (-0.39), less than Alzamend Neuro, Inc. (-0.17), less than Virax Biolabs Group Limited (-0.68), less than Kiromic BioPharma, Inc. (-0.08), less than Benitec Biopharma Inc. (-2.02), less than Cardio Diagnostics Holdings, Inc. (-0.72), less than Sigilon Therapeutics, Inc. (-1.90), less than Sonnet BioTherapeutics Holdings, Inc. (-2.73), less than ZyVersa Therapeutics, Inc. (-0.07), less than X4 Pharmaceuticals, Inc. (6.04), greater than Terns Pharmaceuticals, Inc. (-5.51), greater than 89bio, Inc. (-5.31), less than Cabaletta Bio, Inc. (-2.20), greater than Akero Therapeutics, Inc. (-10.86), greater than Mirum Pharmaceuticals, Inc. (-17.91), less than Inozyme Pharma, Inc. (-3.09), greater than Day One Biopharmaceuticals, Inc. (-17.12), less than HOOKIPA Pharma Inc. (-0.97), greater than Axsome Therapeutics, Inc. (-13.45), less than Incyte Corporation (449.22), greater than ImmunoGen, Inc. (-122.93), less than Sarepta Therapeutics, Inc. (246.20), less than ACADIA Pharmaceuticals Inc. (79.19),

Build a custom stock screener for Brii Biosciences Limited (BRIBF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Brii Biosciences Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Brii Biosciences Limited (BRIBF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Brii Biosciences Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.